Aurora Cannabis Inc. (ACB), announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021 on Thursday, February 10th, 2022, as follows:

Q2 Financial Highlights

(Unless otherwise stated, comparisons are made between fiscal Q2 2022 and Q1 2022 results and are in Canadian dollars)

• Net Revenue: increased 0.8%
  • Medical: increased 11.6%
  • Consumer: decreased 22.4%
• Adj. EBITDA: improved by 25.3%
• Net Profit (Loss): unchanged at $(75.1)M
• SG&A (incl. R&D): reduced by 9.8%
• Cash on Hand: decreased 14.3%

Operational Highlights

• Kilograms Sold: increased 4.5%
• Ave. Net Selling Price: decreased 10.1%

Forward Guidance

• The company
  • reaffirmed its goal of Adjusted EBITDA profitability by H1/2023
  • expects to realize the upper end of $60M-$80M in cost savings by H1/2023

Stock Performance

Canopy's stock price increased today but still remains down -14.2% YTD and still remains down -75.6% from its 2021 high.